Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Intrabody applications in neurological disorders: progress and future prospectsTodd W Miller, Anne MesserMolecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2003
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotypeTodd W Miller, Thomas L Shirley, William J Wolfgang, et al.Proceedings of the National Academy of Sciences of the United States of America|August 3, 2005
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodiesWilliam J Wolfgang, Todd W Miller, Jack M Webster, et al.Neurobiology of Disease|April 20, 2005
A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's diseaseTodd W Miller, Chun Zhou, Silvia Gines, et al.Physiology & Behavior|January 27, 2010
Mini-review: polybrominated diphenyl ether (PBDE) flame retardants as potential autism risk factorsAnne MesserAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Endocrine resistance: what do we know?Todd W MillerExpert Review of Endocrinology & Metabolism|February 14, 2019
Membrane-initiated estrogen signaling: oncogenic or impotent?Todd W MillerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Managing breast cancers with low estrogen receptor and HER2 by drugging bothTodd W MillerBreast Cancer Research : BCR|February 10, 2012
Initiating breast cancer by PIK3CA mutationTodd W MillerBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 21, 2006
The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseasesAnne Messer, Julie McLearPageof 12